Emactuzumab
Emactuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Emactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors).
| Trade Name | Emactuzumab |
| Generic | Emactuzumab |
| Emactuzumab Other Names | Emactuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Emactuzumab
